Company · CIK 1538210

# NexImmune, Inc.

| CIK | [1538210](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001538210) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MD |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-31 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-263399 | Shelf Effective | 2022-03-09 | 2024-08-28 | 6 |
| 333-252220 | IPO Final prospectus | 2021-01-19 | 2021-02-16 | 5 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-08-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1538210/999999999524002655/9999999995-24-002655-index.htm) Declared effective | 333-263399 | 9999999995-24-002655 |
| 2024-02-05 | [424B5](https://www.sec.gov/Archives/edgar/data/1538210/000119312524024111/0001193125-24-024111-index.htm) Shelf takedown | 333-263399 | 0001193125-24-024111 |
| 2023-04-07 | [424B5](https://www.sec.gov/Archives/edgar/data/1538210/000119312523095294/0001193125-23-095294-index.htm) Shelf takedown | 333-263399 | 0001193125-23-095294 |
| 2022-06-17 | [424B5](https://www.sec.gov/Archives/edgar/data/1538210/000119312522176590/0001193125-22-176590-index.htm) Shelf takedown | 333-263399 | 0001193125-22-176590 |
| 2022-03-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1538210/999999999522000658/9999999995-22-000658-index.htm) Declared effective | 333-263399 | 9999999995-22-000658 |
| 2022-03-09 | [S-3](https://www.sec.gov/Archives/edgar/data/1538210/000119312522070714/0001193125-22-070714-index.htm) Shelf registered | 333-263399 | 0001193125-22-070714 |
| 2021-02-16 | [424B4](https://www.sec.gov/Archives/edgar/data/1538210/000119312521045015/0001193125-21-045015-index.htm) Final prospectus | 333-252220 | 0001193125-21-045015 |
| 2021-02-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1538210/999999999521000597/9999999995-21-000597-index.htm) Declared effective | 333-252220 | 9999999995-21-000597 |
| 2021-02-11 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1538210/000119312521037480/0001193125-21-037480-index.htm) Amendment | 333-252220 | 0001193125-21-037480 |
| 2021-02-08 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1538210/000119312521031549/0001193125-21-031549-index.htm) Amendment | 333-252220 | 0001193125-21-031549 |
| 2021-01-19 | [S-1](https://www.sec.gov/Archives/edgar/data/1538210/000119312521011521/0001193125-21-011521-index.htm) Registration filed | 333-252220 | 0001193125-21-011521 |
| 2020-12-14 | [DRS](https://www.sec.gov/Archives/edgar/data/1538210/000095012320012609/0000950123-20-012609-index.htm) Draft made public | 377-03882 | 0000950123-20-012609 |

[All filings of this company](https://equitycapital.markets/filings?cik=1538210) · [CSV](https://equitycapital.markets/filings.csv?cik=1538210)

---
Source page: https://equitycapital.markets/company/1538210 · Data: U.S. SEC EDGAR · CC BY 4.0